drugset / Trial / NCT03943251
The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study is a safety, tolerability, and pharmacokinetics phase Ⅰstudy of a selective Serotonin partial agonist and reuptake inhibitors, HEC113995PA•H2O,in healthy subjects.This study is the healthy adult subjects single ascending-dose research.
Timeline
- Start
- 2019-07-04
- Primary completion
- 2019-12-11
- Completion
- 2019-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC113995PA•H2O | Unknown | 2.5 mg | — |
| Subject | HEC113995PA•H2O | Unknown | 5 mg | — |
| Subject | HEC113995PA•H2O | Unknown | 10 mg | — |
| Subject | HEC113995PA•H2O | Unknown | 20 mg | — |
| Subject | HEC113995PA•H2O | Unknown | 40 mg | — |
| Subject | HEC113995PA•H2O | Unknown | 60 mg | — |
| Subject | HEC113995PA•H2O | Unknown | 80 mg | — |
Indications
No indication recorded.